Impact of Definitive Drug–Drug Interaction Testing on Medication Management and Patient Care
Abstract Background and Objective Aegis Sciences Corporation developed a test (InterACT Rx™) that objectively and definitively identifies substances known to interact with drug–drug interaction-prone medications commonly prescribed in the treatment of chronic pain and behavioral health disorders. Th...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2018-10-01
|
Series: | Drugs - Real World Outcomes |
Online Access: | http://link.springer.com/article/10.1007/s40801-018-0143-z |